Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why BioNTech Stock Sank Today

TheMotleyFool

0 0

Coronavirus stock BioNTech (NASDAQ: BNTX) isn't having a good time of it lately. On Wednesday, the company's shares slid yet again, falling by nearly 6% after another coronavirus stock posted good news, and an analyst cut her price target on the biotech's shares.

On Tuesday, fellow COVID vaccine developer Moderna happily announced that the European Medicines Agency (EMA) authorized a third dose of its two-shot mRNA-1273 (brand-named Spikevax) for severely immunocompromised people age 12 and older. That's a big deal, since the EMA covers the sprawling 27-member European Union.

Image source: Getty Images.

Source Fool.com

Like: 0

BNTX

Teilen